Early Management Strategies of Acute Heart Failure for Patients With NSTEMI
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 470 participants.
Also called NCT03189901
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 470 participants
- Registry
-
NCT03189901
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT03189901. Randomized; no masking; primary purpose treatment. Start 2017-07-01 (actual); primary completion 2021-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Early Management Strategies of Acute Heart Failure for Patients With NSTEMI
- Acronym
- EMSAHF
- Condition
- Early Management
- Condition
- Acute Heart Failure
- Condition
- NSTEMI - Non-ST Segment Elevation MI
- Intervention (Drug)
- Regular management+Levosimendan
- Lead sponsor
- Qilu Hospital of Shandong University
Record details
- Record id
cardio:ct-nct03189901- Content hash
7689459863635e883b68907e81e94b32b9828740a40e485c4b88e6c5aac1248e